NCT00331526View on ClinicalTrials.gov

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2012

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic autologous lymphocytes

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

Trial Locations (1)

92663

Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach

All Listed Sponsors
lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00331526 - Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter